Holen Sie sich die Stockscreener-App
6.565
5.79%
-0.425
Zura Bio Ltd Aktie (ZURA) Neueste Nachrichten
Zura Bio launches Phase 2 TibuSURE trial in systemic sclerosis at Athens congress - Traders Union
Zura Bio presents Phase 2 systemic sclerosis trial design By Investing.com - Investing.com India
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress - Yahoo Finance Singapore
Major Zura Bio (ZURA) holder acquires 2M shares in registered deal - Stock Titan
Access Industries group lifts Zura Bio (ZURA) stake to 18.2% - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Zura Bio heads to Miami for March 10-11 investor conferences - Stock Titan
Zura Bio raises $144 million in public offering of shares By Investing.com - Investing.com South Africa
Zura Bio raises $144 million in public offering of shares - Investing.com India
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - ChartMill
ZURA Should I Buy - Intellectia AI
Zura Bio (ZURA) revises Ogier legal opinion and consent in 8-K/A - Stock Titan
Zura Bio prices $125M public offering at $6.25 per share - Investing.com Australia
Zura Bio (ZURA) launches $6.25 share and pre-funded warrant sale - Stock Titan
Zura Bio (NASDAQ: ZURA) seeks roughly $117M from 18.2M-share offering - Stock Titan
Zura Bio Prices Public Offering of 18.2 Million Shares - Intellectia AI
Zura Bio prices $125M public offering at $6.25 per share By Investing.com - Investing.com South Africa
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - ChartMill
Director Mark Eisner files initial Form 3 for Zura Bio Ltd (ZURA) - Stock Titan
Zura Bio launches public offering of Class A shares By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Stock Titan
Zura Bio adds two immunology executives to board By Investing.com - Investing.com India
Zura Bio adds two immunology executives to board - Investing.com Australia
Zura Bio (ZURA) appoints Mark Eisner and Ajay Nirula to its board - Stock Titan
Leaders behind four approved immunology drugs join Zura Bio board - Stock Titan
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors - Yahoo Finance
Risk Recap: What makes Zura Bio Limited stock attractive todayMarket Sentiment Report & Community Consensus Picks - baoquankhu1.vn
What risks investors should watch in Zura Bio Limited stockGDP Growth & Weekly High Momentum Picks - mfd.ru
Great Point discloses 3.8M Zura Bio (ZURA) shares in 13G/A - Stock Titan
Zura Bio Highlights Key Phase 2 Tibulizumab Readouts at Guggenheim Biotech Summit 2026 - Yahoo Finance
Why retail investors favor Zura Bio Limited stockWeekly Stock Recap & Daily Momentum Trading Reports - mfd.ru
ZURA PE Ratio & Valuation, Is ZURA Overvalued - Intellectia AI
Zura Bio Advances Tibulizumab Strategy in Autoimmune Diseases - TipRanks
Zura Bio Ltd Provides Updated Corporate Presentation - TradingView
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wedbush initiates coverage on Zura Bio stock with Outperform rating By Investing.com - Investing.com India
Wedbush initiates coverage on Zura Bio stock with Outperform rating - Investing.com
Wedbush Initiates Zura Bio at Outperform With $15 Price Target - marketscreener.com
Investment Report: Will Zura Bio Limited benefit from rising consumer demand2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
Aug Update: Will Zura Bio Limited benefit from rising consumer demandJuly 2025 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit - ChartMill
Watch Zura Bio's Guggenheim biotech summit fireside chat live online - Stock Titan
Aug Sectors: What makes Zura Bio Limited stock attractive todayTrade Risk Assessment & Capital Protection Trading Alerts - baoquankhu1.vn
Zura Bio Limited (NASDAQ:ZURA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Pre-market volume spike for 94E.F Zura Bio (XETRA) 28 Jan 2026: watch EUR 5.20 level - Meyka
Zura Bio (NASDAQ:ZURA) Trading Up 0.3%What's Next? - MarketBeat
Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for Director Parvinder Thiara - Longbridge
Zura Bio Ltd Announces CEO Transition and Board Appointment - TradingView
Does Zura Bio Limited have pricing power2025 Technical Overview & Weekly Consistent Profit Watchlists - mfd.ru
CEO shake-up at Zura Bio (NASDAQ: ZURA) with new director added - Stock Titan
Can Zura Bio Limited stock double in the next yearJuly 2025 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Zura Bio appoints Sandeep Kulkarni as new CEO By Investing.com - Investing.com South Africa
Aug Summary: Is OAKPRB stock showing strong momentum2025 Retail Activity & AI Enhanced Trading Alerts - baoquankhu1.vn
Zura Bio stock jumps after CEO appointment from Tourmaline Bio By Investing.com - Investing.com South Africa
Zura Bio stock jumps after CEO appointment from Tourmaline Bio - Investing.com
Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On WednesdayAmerican Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM) - Benzinga
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Weekly Voice
Ex-Tourmaline CEO who led company’s sale to Novartis takes helm at Zura Bio - Stock Titan
How Zura Bio Limited stock performs during Fed tightening cyclesCandlestick Pattern Analysis & Free Realize Exceptional Returns - bollywoodhelpline.com
RSI Check: What is Zura Bio Limiteds TAM Total Addressable MarketJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - baoquankhu1.vn
Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga
Aug Drivers: Should you avoid Zura Bio Limited stock right nowEarnings Summary Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
4.16%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):